(Q44489055)

3 December 2017

Prediction of outcome in the treatment of onychomycosis (English)

1 reference

3 December 2017

Sommer S

1

1 reference

3 December 2017

Sheehan-Dare RA

series ordinal

2

1 reference

3 December 2017

Goodfield MJ

series ordinal

3

1 reference

3 December 2017

Evans EG

series ordinal

4

1 reference

3 December 2017

1 July 2003

1 reference

Clinical and Experimental Dermatology

3 December 2017

1 reference

3 December 2017

28

1 reference

3 December 2017

4

1 reference

3 December 2017

425-428

1 reference

Is tinea unguium still widely incurable? A review three decades after the introduction of griseofulvin

3 December 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2003.01308.X

Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. The LION Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2003.01308.X

How often does oral treatment of toenail onychomycosis produce a disease-free nail? An analysis of published data

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2003.01308.X

Prognostic factors of mycological cure following treatment of onychomycosis with oral antifungal agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2003.01308.X

Subungual dermatophytoma complicating dermatophyte onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2003.01308.X

A new classification of onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2003.01308.X

10.1046/J.1365-2230.2003.01308.X

21 January 2018

Identifiers

DOI

1 reference

3 December 2017

1 reference